Published Date : Jul 31, 2017
ALBANY, New York, July 31, 2017: A new report has been added by MarketResearchReports.biz to its database about the stent grafts market. The latest report, titled “Global EVAR Stent Grafts Market Professional Survey Report 2017” adds an exclusive discussion to analyze the market by depending on the following product type namely thoracic aortic stent grafts and abdominal aortic stent grafts. EVAR is a minimally invasive alternate for repairing of abdominal aortic aneurysms (AAA’s). This is also used for the treatment of thoracic aortic aneurysms. Rise in these incidences of aneurysms is the major factor for the EVAR stent grafts market growth.
Drivers such as increasing acceptance of EVAR procedures, rising demand for minimally invasive endovascular surgeries, aging population and rising incidences in obesity and diabetes and technological advancements has been anticipated for the future growth in the stent grafts market. The report has listed an exclusive overview on the latest technological trends for EVAR stent grafts market which has been predicted to create a fast-growing market to earn better response rate and faster development. The report has analyzed few factors for restraining the growth of the market such as increasing acceptance of balloon angioplasty.
The global EVAR stent grafts market has been divided into three categories. Based on the types, the market has been divided into abdominal aortic stent grafts and thoracic aortic stent grafts. Based on the applications, the market has been segmented into ruptured AAA treatment, traumatic aortic injury treatment and other. For each segment, the report provides data on the status and outlook for the larger applications in terms of market shares, growth rate, and current consumption rates to gain the better market growth over the coming years.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1102950
The key countries in the global EVAR stent grafts market have been vastly discussed in the report, including North America, E.U., China, Japan, Southeast Asia and India. Each geographical segment has been explained in terms of the development, number of prominent players, the recent state of activities in those countries pertaining to the global EVAR stent grafts market and lastly the scope for growth in the market in those countries over the forecast period by 2022.
A detailed reports of competitive landscape has also been provided in the report. This section covers the intensity of the competition in the market and the role of the key players has also been discussed in the report. The list of key players who are trying to avoid the curve, includes Medtronic, Boston Scientific, Cardial Health (Cordis, Endologix, Microport Scientific, Trivascular, Terumo (Vascutek). For each key player, the report intricates on their regional prominence, market share and growth in terms of revenue, price, and sales. The report also includes a brief note on the competitors of each of the key players which is based on the competitive status and trends, market concentration rate, different services and the new entrants.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org